PMID- 18355242 OWN - NLM STAT- MEDLINE DCOM- 20081010 LR - 20220309 IS - 1365-2567 (Electronic) IS - 0019-2805 (Print) IS - 0019-2805 (Linking) VI - 125 IP - 1 DP - 2008 Sep TI - Serum-derived exosomes from antigen-fed mice prevent allergic sensitization in a model of allergic asthma. PG - 21-7 LID - 10.1111/j.1365-2567.2008.02812.x [doi] AB - Oral tolerance is an active process that starts with sampling of luminal antigens by the intestinal epithelial cells (IEC), followed by processing and assembly with major histocompatibility complex class II and subsequently a release of tolerogenic exosomes (tolerosomes) from the IEC. We have previously shown that tolerosomes can be isolated from serum shortly after an antigen feed, and will potently transfer antigen-specific tolerance to naive recipients. Here we study the capacity of the tolerosomes to protect against allergic sensitization in a mouse model of allergic asthma. Serum or isolated serum exosomes from tolerized BALB/c donor mice were transferred to syngeneic recipients followed by sensitization and intranasal exposure to ovalbumin (OVA). Blood, bronchoalveolar lavage (BAL) and lymph nodes were sampled 24 hr after the final exposure. The number of eosinophils was counted in BAL fluid and the levels of immunoglobulin E (IgE) and OVA-specific IgE were measured in serum. Mediastinal and coeliac lymph nodes were analysed by flow cytometry. The animals receiving serum from OVA-fed mice displayed significantly lower numbers of airway eosinophils and lower serum levels of total IgE as well as of OVA-specific IgE compared with controls. Moreover, the tolerant animals showed a significantly higher frequency of activated T cells with a regulatory phenotype in both mediastinal and coeliac lymph nodes. The results show that serum or isolated serum exosomes obtained from OVA-fed mice and administered intraperitoneally to naive recipient mice abrogated allergic sensitization in the recipients. FAU - Almqvist, Nina AU - Almqvist N AD - Department of Rheumatology and Inflammation Research, Goteborg University, Goteborg, Sweden. nina.almqvist@rheuma.gu.se FAU - Lonnqvist, Anna AU - Lonnqvist A FAU - Hultkrantz, Susanne AU - Hultkrantz S FAU - Rask, Carola AU - Rask C FAU - Telemo, Esbjorn AU - Telemo E LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20080319 PL - England TA - Immunology JT - Immunology JID - 0374672 RN - 0 (Allergens) RN - 0 (Immune Sera) RN - 37341-29-0 (Immunoglobulin E) RN - 9006-59-1 (Ovalbumin) SB - IM MH - Allergens/immunology MH - Animals MH - Asthma/immunology/*prevention & control MH - Bronchoalveolar Lavage Fluid/immunology MH - Cytoplasmic Vesicles/*immunology MH - Disease Models, Animal MH - Immune Sera/immunology MH - Immune Tolerance MH - Immunity, Mucosal MH - Immunoglobulin E/blood MH - Intestinal Mucosa/immunology MH - Liver/immunology MH - Lung/immunology MH - Lymph Nodes/immunology MH - Male MH - Mice MH - Mice, Inbred BALB C MH - Ovalbumin/immunology MH - Passive Cutaneous Anaphylaxis/immunology MH - Rats MH - Rats, Sprague-Dawley MH - T-Lymphocytes, Regulatory/immunology PMC - PMC2526256 EDAT- 2008/03/22 09:00 MHDA- 2008/10/11 09:00 PMCR- 2009/09/01 CRDT- 2008/03/22 09:00 PHST- 2008/03/22 09:00 [pubmed] PHST- 2008/10/11 09:00 [medline] PHST- 2008/03/22 09:00 [entrez] PHST- 2009/09/01 00:00 [pmc-release] AID - IMM2812 [pii] AID - 10.1111/j.1365-2567.2008.02812.x [doi] PST - ppublish SO - Immunology. 2008 Sep;125(1):21-7. doi: 10.1111/j.1365-2567.2008.02812.x. Epub 2008 Mar 19.